US 11667637
Fused imidazo-piperidine JAK inhibitors
granted A61KA61K31/437A61P
Quick answer
US patent 11667637 (Fused imidazo-piperidine JAK inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/437, A61P, A61P11/00, A61P11/06